EPIDEMIOLOGICAL FEATURES AND RISK FACTORS OF MUSCULOSKELETAL AND CONNECTIVE TISSUE DISEASES
DOI:
https://doi.org/10.32782/2306-2436.14.2.2024.312Keywords:
non-communicable diseases; pain syndromes; risk factors; prevalence, morbidity and disability; public health.Abstract
Abstract. Background. The relevance of the study is due to the medical, social and economic importance of diseases of the musculoskeletal system and connective tissue, which make a significant contribution to the burden of diseases and disabilities of the world population. Purpose. To carry out an analysis of the incidence of diseases of the musculoskeletal system and connective tissue among the world's population and Ukraine, and the factors that cause them. Materials and methods. The data used were those of the study on the global burden of diseases, injuries and risk factors, meta-analyses and systematic reviews; data from the State Statistics Service of Ukraine, medical statistics from the Public Health Centre of the Ministry of Health of Ukraine. Methods: bibliosemantic, comparative, statistical analysis, generalization. Results. It was established that in 2017, among the world population, the age-standardized prevalence, mortality and disability rates for diseases of the musculoskeletal system and connective tissue were 16,276.2, 1.6 and 1,720 per 100,000 of us, respectively, and in 2021, 19,832, 1.43 and 1,908.87 per 100,000 of us, respectively. The highest prevalence is due to low back pain (36.8%), other diseases of this class (21.5%), osteoarthritis (19.3%), and neck pain (18.4%), as well as gout (2.6%), rheumatoid arthritis (1.3%). In Ukraine, these diseases occupy more than 5.0% of the structure of all registered diseases and occupy the fourth rank place, and among those detected for the first time – 4.0%, and occupy the seventh place. In the structure of primary disability of the adult population, these diseases belong to the third place, or more than 11.0% of cases. Primary morbidity, prevalence and disability levels during 1993–2017 had a steady upward trend. Age and female gender are recognized as unmodified risk factors for diseases of the musculoskeletal system, and low physical activity, obesity, smoking, and poor nutrition are recognized as modified. Conclusions. The dynamics of prevalence rates and population disability from diseases of the musculoskeletal system and connective tissue are unfavourable, exacerbated by numerous modified and unmodified risk factors.
References
1. Briggs AM, Woolf AD, Dreinhöfer K, Homb N, Hoy DG, Kopansky-Giles D, Åkesson K, March L. Reducing the global burden of musculoskeletal conditions. Bull World Health Organ. 2018; 96(5):366–368. DOI: 10.2471/BLT.17.204891.
2. World Health Organization. Musculoskeletal health. Available from: https://www.who.int/news-room/fact-sheets/ detail/musculoskeletal-conditions.
3. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Identifying Disabling Medical Conditions Likely to Improve with Treatment. Selected Health Conditions and Likelihood of Improvement with Treatment. Washington (DC): National Academies Press (US); 2020. Musculoskeletal Disorders. DOI: 10.17226/25662. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559512/.
4. Prevalence, Deaths, and Disability-Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017. Safiri S, Kolahi AA, Cross M, et al. Arthritis Rheumatol. 2021; 73(4):702–714. DOI: 10.1002/art.41571.
5. Zhou J, Xie S, Xu S, Zhang Y, Li Y, Sun Q, Zhang J, Zhao T. From Pain to Progress: Comprehensive Analysis of Musculoskeletal Disorders Worldwide. J Pain Res. 2024; 17:3455–3472. Available from: https://doi.org/10.2147/JPR.S488133.
6. Blyth FM. Global burden of neuropathic pain. Pain. 2018 Mar;159(3):614–617. DOI: 10.1097/j.pain.0000000000001127.
7. Blyth FM., Briggs AM., Schneider CH., Hoy DG., March LM. The Global Burden of Musculoskeletal Pain-Where to From Here? Am J Public Health. 2019; 109(1):35–40. DOI: 10.2105/ AJPH.2018.304747.
8. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204–1222. DOI: https://doi.org/10.1016/S0140-6736(20)30925-9.
9. Murray CJL. The Global Burden of Disease Study at 30 years. Nat Med. 2022; 28:2019–2026. https://doi.org/10.1038/ s41591-022-01990-1.
10. GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023; 5(6):e316–e329. DOI: 10.1016/S2665-9913(23)00098-X.
11. GBD 2021 Neck Pain Collaborators. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024; 6(3):e142–e155. DOI: 10.1016/S2665-9913(23)00321-1.
12. Cimas M, Ayala A, Sanz B, Agulló-Tomás MS, Escobar A, Forjaz MJ. Chronic musculoskeletal pain in European older adults: Cross-national and gender differences. Eur J Pain. 2018; 22(2):333–345. DOI: 10.1002/ejp.1123.
13. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023; 5(9):e508–e522. DOI: 10.1016/S2665-9913(23)00163-7.
14. G Hsu H, Siwiec RM. Knee Osteoarthritis. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
15. Leifer VP, Katz JN, Losina E. The burden of OA-health services and economics. Osteoarthritis Cartilage. 2022; 30(1):10–16. DOI: 10.1016/j.joca.2021.05.007.
16. Chang X, Xu S, Zhang H. Regulation of bone health through physical exercise: Mechanisms and types. Front Endocrinol (Lausanne). 2022; 13:1029475. DOI: 10.3389/ fendo.2022.1029475.
17. Cai Y, Zhang J, Liang J, Xiao M, Zhang G, Jing Z, Lv L, Nan K, Dang X. The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis. J Clin Med. 2023; 12(4):1291. DOI: 10.3390/jcm12041291.
18. Frazzei G, Musters A, de Vries N, Tas SW, van Vollenhoven RF. Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals. Autoimmun Rev. 2023; 22(1):103217. DOI: 10.1016/j.autrev.2022.103217.
19. Ponyk RM, Korytko ZI. Zakhvoriuvanist ta osoblyvosti reabilitatsii khvorykh na revmatoidnyi artryt v umovakh sohodennia [Incidence and features of rehabilitation of patients with rheumatoid arthritis in the present conditions. Achievements of clinical and experimental medicine]. Zdobutky klinichnoi i eksperymentalnoi medytsyny 2019; 3:183–187. DOI: 10.11603/ 1811-2471.2019.v.i3.10504.
20. GBD 2021 Gout Collaborators. Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024; 6(8):e507–e517. DOI: 10.1016/ S2665-9913(24)00117-6.
21. Punjwani S, Jani C, Liu W, et al. Burden of gout among different WHO regions, 1990–2019: estimates from the global burden of disease study. Sci Rep 2024; 14:15953. https://doi.org/10.1038/s41598-024-61616-z.
22. Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Gill TK, Manasi MM, Lyn MM, et al. The Lancet Rheumatology 2023; 5(11):e670–e682.
23. Dolhopolov OV, Polishko VP, Yarova ML. Epidemiolohiia zakhvoriuvan kistkovo-miazovoi systemy v Ukraini za period 1993–2017 rr. [Epidemiology of musculoskeletal diseases in Ukraine for the period 1993–2017]. Visnyk ortopedii, travmatolohii, protezuvannia. 2019; 103:96–104. DOI: 10.37647/0132-2486-2019-103-4-96-104.
24. Lewis R, Gómez Álvarez CB, Rayman M, Lanham-New S, Woolf A, Mobasheri A. Strategies for optimising musculoskeletal health in the 21st century. BMC Musculoskelet Disord. 2019; 20(1):164. DOI: 10.1186/s12891-019-2510-7.
25. Malik KM, Beckerly R, Imani F. Musculoskeletal Disorders a Universal Source of Pain and Disability Misunderstood and Mismanaged: A Critical Analysis Based on the U.S. Model of Care. Anesth Pain Med. 2018; 8(6):e85532. DOI: 10.5812/ aapm.85532.
26. Espirito Santo CM, Santos VS, Kamper SJ, Williams CM, Miyamoto GC, Yamato TP. Overview of the economic burden of musculoskeletal pain in children and adolescents: a systematic review with meta-analysis. Pain. 2024; 165(2):296–323. DOI: 10.1097/j.pain.0000000000003037.
27. Chen N, Fong DYT, Wong JYH. Health and Economic Outcomes Associated with Musculoskeletal Disorders Attributable to High Body Mass Index in 192 Countries and Territories in 2019. JAMA Netw Open. 2023; 6(1):e2250674. DOI: 10.1001/ jamanetworkopen.2022.50674.
28. Sedlak S, Jelenc M. Solutions for reducing the severe economic burden of musculoskeletal diseases, European Journal of Public Health, 2024; 34(Supplement_3):ckae144.2089. Available from: https://doi.org/10.1093/eurpub/ckae144.2089.
29. Chen N, Fong DYT, Wong JYH. Health and economic burden of low back pain and rheumatoid arthritis attributable to smoking in 192 countries and territories in 2019. Addiction. 2024; 119:677–685. DOI: https://doi.org/10.1111/add.16404.
30. Kemmak AR, Rezapour A, Jahangiri R, Nikjoo S, Farabi H, Soleimanpour S. Economic burden of osteoporosis in the world: A systematic review. Med J Islam Repub Iran. 2020; 34:154. DOI: 10.34171/mjiri.34.154.
